Capital Investment Advisory Services’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.07M Sell
48,851
-777
-2% -$144K 0.74% 28
2025
Q1
$10.4M Buy
49,628
+11,576
+30% +$2.43M 0.93% 18
2024
Q4
$6.76M Sell
38,052
-516
-1% -$91.7K 0.65% 32
2024
Q3
$7.62M Sell
38,568
-1,587
-4% -$313K 0.72% 27
2024
Q2
$6.89M Buy
40,155
+108
+0.3% +$18.5K 0.71% 30
2024
Q1
$7.29M Sell
40,047
-2,144
-5% -$390K 0.78% 21
2023
Q4
$6.54M Buy
42,191
+1,053
+3% +$163K 0.6% 30
2023
Q3
$6.13M Sell
41,138
-452
-1% -$67.4K 0.6% 25
2023
Q2
$5.6M Buy
41,590
+482
+1% +$64.9K 0.55% 28
2023
Q1
$6.55M Sell
41,108
-1,730
-4% -$276K 0.77% 23
2022
Q4
$6.92M Buy
42,838
+9,382
+28% +$1.52M 0.82% 19
2022
Q3
$4.49M Sell
33,456
-461
-1% -$61.9K 0.58% 33
2022
Q2
$5.2M Buy
33,917
+2,774
+9% +$425K 0.63% 28
2022
Q1
$5.05M Buy
31,143
+486
+2% +$78.8K 0.55% 29
2021
Q4
$4.15M Buy
30,657
+1,271
+4% +$172K 0.49% 44
2021
Q3
$3.17M Buy
29,386
+2,530
+9% +$273K 0.4% 51
2021
Q2
$3.03M Sell
26,856
-281
-1% -$31.7K 0.38% 58
2021
Q1
$2.94M Buy
27,137
+164
+0.6% +$17.7K 0.41% 54
2020
Q4
$2.89M Buy
26,973
+1,826
+7% +$196K 0.43% 52
2020
Q3
$2.2M Sell
25,147
-2,860
-10% -$251K 0.41% 58
2020
Q2
$2.75M Buy
28,007
+167
+0.6% +$16.4K 0.56% 40
2020
Q1
$2.12M Sell
27,840
-3,099
-10% -$236K 0.52% 40
2019
Q4
$2.74M Buy
30,939
+3,262
+12% +$289K 0.73% 26
2019
Q3
$2.1M Buy
27,677
+12,337
+80% +$934K 0.58% 33
2019
Q2
$1.04M Buy
15,340
+6,759
+79% +$460K 0.32% 65
2019
Q1
$692K Buy
8,581
+193
+2% +$15.6K 0.26% 77
2018
Q4
$773K Sell
8,388
-740
-8% -$68.2K 0.33% 58
2018
Q3
$863K Buy
9,128
+20
+0.2% +$1.89K 0.4% 59
2018
Q2
$844K Buy
9,108
+3,693
+68% +$342K 0.42% 58
2018
Q1
$513K Buy
5,415
+1,035
+24% +$98.1K 0.29% 85
2017
Q4
$424K Buy
4,380
+705
+19% +$68.2K 0.25% 103
2017
Q3
$327K Sell
3,675
-8,340
-69% -$742K 0.2% 124
2017
Q2
$871K Sell
12,015
-706
-6% -$51.2K 0.57% 43
2017
Q1
$829K Sell
12,721
-35
-0.3% -$2.28K 0.61% 41
2016
Q4
$799K Buy
+12,756
New +$799K 0.69% 40